0
Skip to Content
ALIMTAS BIOVENTURES
ABOUT
TEAM
ADVISORY BOARD
PARTNERS
PROJECTS
AB-101: Smart Scaffolds for Tissue Regeneration
AB-201: Novel Small Molecule HBV Therapeutics
AB-301: HTS for the Discovery of Covid-19 Therapeutics
AB-302: Gene Therapy Vectors for Increased Genetic Payload and Long Term Expression
AB-401: Drug Encapsulation with Optimeos
AB-402: Accelerated Wound Healing via Electrotaxis
AB-501: Crx-1k, a Novel and Potent Therapeutic for C. difficile
HIGHLIGHTS
Open Menu
Close Menu
ALIMTAS BIOVENTURES
ABOUT
TEAM
ADVISORY BOARD
PARTNERS
PROJECTS
AB-101: Smart Scaffolds for Tissue Regeneration
AB-201: Novel Small Molecule HBV Therapeutics
AB-301: HTS for the Discovery of Covid-19 Therapeutics
AB-302: Gene Therapy Vectors for Increased Genetic Payload and Long Term Expression
AB-401: Drug Encapsulation with Optimeos
AB-402: Accelerated Wound Healing via Electrotaxis
AB-501: Crx-1k, a Novel and Potent Therapeutic for C. difficile
HIGHLIGHTS
Open Menu
Close Menu
ABOUT
TEAM
ADVISORY BOARD
PARTNERS
Folder:
PROJECTS
Back
AB-101: Smart Scaffolds for Tissue Regeneration
AB-201: Novel Small Molecule HBV Therapeutics
AB-301: HTS for the Discovery of Covid-19 Therapeutics
AB-302: Gene Therapy Vectors for Increased Genetic Payload and Long Term Expression
AB-401: Drug Encapsulation with Optimeos
AB-402: Accelerated Wound Healing via Electrotaxis
AB-501: Crx-1k, a Novel and Potent Therapeutic for C. difficile
HIGHLIGHTS